Zura Bio (ZURA) has provided an update.
Zura Bio Limited has navigated a CEO transition, with Someit Sidhu stepping down and Robert Lisicki taking over on April 8, 2024. Sidhu’s departure comes with a financial package including salary, notice, termination compensation, and severance totaling over $555,000. Additionally, Sidhu’s stock options will accelerate, making 1,000,000 shares immediately exercisable, with more vesting over the next three years. His contribution to a recent capital raise also ensures 700,000 shares remain exercisable until expiration.
See more data about ZURA stock on TipRanks’ Stock Analysis page.
